What are Crinetics Pharmaceuticals's profit margins?

Crinetics Pharmaceuticals (CRNX) runs a 150.0% gross margin and a -3020.3% operating margin, with a -2747.2% net margin.

Where do Crinetics Pharmaceuticals's ratios come from?

Every ratio is computed from Crinetics Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Crinetics Pharmaceuticals CRNX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-6,714.8%+25,899pp	-32,613.5%-27,066pp	-5,547.2%-2,003pp	-3,544.1%+6,447pp
Net margin	-6,046.2%+22,674pp	-28,720.7%-23,375pp	-5,345.9%-1,885pp	-3,460.4%+6,525pp
EBITDA margin	-6,664.2%+25,681pp	-32,345.4%-26,826pp	-5,519.8%-1,997pp	-3,523.3%+6,382pp
Free cash flow margin	-4,985.5%+17,540pp	-22,525.3%-18,207pp	-4,318.1%-1,851pp	-2,467%+5,791pp
Returns
Return on equity	-40.2%-8.1pp	-32%+18.1pp	-50.2%+0.4pp	-50.6%-7.6pp
Return on assets	-36.3%-7.5pp	-28.8%+14.6pp	-43.4%+3.2pp	-46.6%-6.3pp
Return on invested capital	-50.4%-9.3pp	-41.2%+13.0pp	-54.2%+25.4pp	-79.6%+20.2pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Liquidity
Current ratio	12.3×-10.7×	23×+10.0×	13.1×+0.6×	12.5×-9.1×
Quick ratio	12.3×-10.7×	23×+10.0×	13.1×+0.6×	12.5×-9.1×
Cash ratio	1.2×-3.3×	4.5×+3.2×	1.3×+0.1×	1.2×-11.4×
Leverage
Debt-to-equity	0×0.0×	0×-0.1×	0.1×+0.1×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0.1×+0.1×	0×0.0×
Per Share
Book value per share	$10.55-35.7%	$16.40+76.7%	$9.28+52.6%	$6.09-29.5%
Valuation
Market capitalization	$4.42B-6.8%	$4.74B+99.5%	$2.38B+141%	$984.73M-27.0%
Enterprise value	$4.36B-3.6%	$4.53B+90.9%	$2.37B+148%	$955.13M-17.1%
Price / sales	574×-3,990×	4,563.7×+3,971×	592.3×+384×	207.9×-1,044×
Price / book	4.5×+0.9×	3.6×-0.8×	4.4×+1.3×	3.1×-1.0×
EV / sales	567×-3,791×	4,357.6×+3,766×	591.1×+390×	201.6×-868×
Free cash flow yield	-8.7%-3.8pp	-4.9%+2.4pp	-7.3%+4.6pp	-11.9%-5.3pp
Earnings yield	-10.5%-4.2pp	-6.3%+2.7pp	-9%+7.6pp	-16.6%-8.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Crinetics Pharmaceuticals's profit margins?: Crinetics Pharmaceuticals (CRNX) runs a 150.0% gross margin and a -3020.3% operating margin, with a -2747.2% net margin.
Where do Crinetics Pharmaceuticals's ratios come from?: Every ratio is computed from Crinetics Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.